Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

MLA

Núñez-Manchón, Judit, et al. “Manifesting Heterozygotes in McArdle Disease: A Myth or a Reality-Role of Statins.” Journal of Inherited Metabolic Disease, vol. 41, no. 6, Nov. 2018, pp. 1027–35. EBSCOhost, https://doi.org/10.1007/s10545-018-0203-2.

APA

Núñez-Manchón, J., Ballester-Lopez, A., Koehorst, E., Linares-Pardo, I., Coenen, D., Ara, I., Rodriguez-Lopez, C., Ramos-Fransi, A., Martínez-Piñeiro, A., Lucente, G., Almendrote, M., Coll-Cantí, J., Pintos-Morell, G., Santos-Lozano, A., Arenas, J., Martín, M. A., de Castro, M., Lucia, A., Santalla, A., & Nogales-Gadea, G. (2018). Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins. Journal of Inherited Metabolic Disease, 41(6), 1027–1035. https://doi.org/10.1007/s10545-018-0203-2

Chicago

Núñez-Manchón, Judit, Alfonsina Ballester-Lopez, Emma Koehorst, Ian Linares-Pardo, Daniëlle Coenen, Ignacio Ara, Carlos Rodriguez-Lopez, et al. 2018. “Manifesting Heterozygotes in McArdle Disease: A Myth or a Reality-Role of Statins.” Journal of Inherited Metabolic Disease 41 (6): 1027–35. doi:10.1007/s10545-018-0203-2.